Detailed information for compound 941425

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 476.006 | Formula: C24H27ClFN3O2S
  • H donors: 4 H acceptors: 1 LogP: 4.87 Rotable bonds: 12
    Rule of 5 violations (Lipinski): 1
  • SMILES: O[C@H](COc1ccccc1)CNCCc1ccc(cc1)NC(=S)Nc1ccc(cc1)F.Cl
  • InChi: 1S/C24H26FN3O2S.ClH/c25-19-8-12-21(13-9-19)28-24(31)27-20-10-6-18(7-11-20)14-15-26-16-22(29)17-30-23-4-2-1-3-5-23;/h1-13,22,26,29H,14-17H2,(H2,27,28,31);1H/t22-;/m0./s1
  • InChiKey: ONHDRGDOMWFVEB-FTBISJDPSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens adrenoceptor beta 3 Starlite/ChEMBL References
Homo sapiens adrenoceptor beta 1 Starlite/ChEMBL References
Homo sapiens adrenoceptor beta 2, surface Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Trichomonas vaginalis PIKK family atypical protein kinase 0.0134 0.0316 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0134 0.0316 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0134 0.0316 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0134 0.0316 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0134 0.0316 1
Trichomonas vaginalis conserved hypothetical protein 0.0084 0.0047 0.1478
Trypanosoma brucei phosphatidylinositol 4-kinase, putative 0.0134 0.0316 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0134 0.0316 1
Trypanosoma cruzi Phosphatidylinositol 3-kinase tor1 0.0134 0.0316 0.0978
Trichomonas vaginalis PIKK family atypical protein kinase 0.0134 0.0316 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0134 0.0316 1
Trypanosoma cruzi Phosphatidylinositol 3-kinase tor2 0.0134 0.0316 0.0978
Trichomonas vaginalis PIKK family atypical protein kinase 0.0134 0.0316 1
Trypanosoma cruzi phosphatidylinositol 3-related kinase, putative 0.0134 0.0316 0.0978
Toxoplasma gondii target of rapamycin (TOR), putative 0.0134 0.0316 1
Loa Loa (eye worm) phosphatidylinositol 3 0.0134 0.0316 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0134 0.0316 1
Trypanosoma brucei target of rapamycin kinase 3, putative 0.0134 0.0316 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0134 0.0316 1
Echinococcus multilocularis phosphatidylinositol 3 and 4 kinase 0.0134 0.0316 0.0316
Trichomonas vaginalis PIKK family atypical protein kinase 0.0134 0.0316 1
Trypanosoma cruzi hypothetical protein, conserved 0.0672 0.3232 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0134 0.0316 1
Trypanosoma cruzi target of rapamycin kinase 3 0.0134 0.0316 0.0978
Trypanosoma brucei FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative 0.0084 0.0047 0.1478
Schistosoma mansoni ataxia telangiectasia mutated (atm)-related 0.0134 0.0316 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0134 0.0316 1
Trypanosoma brucei Phosphatidylinositol 3-kinase tor1 0.0134 0.0316 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0134 0.0316 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0134 0.0316 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0134 0.0316 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0134 0.0316 1
Leishmania major hypothetical protein, conserved 0.0698 0.3371 1
Trypanosoma cruzi phosphatidylinositol 3-related kinase, putative 0.0134 0.0316 0.0978
Trichomonas vaginalis PIKK family atypical protein kinase 0.0134 0.0316 1
Toxoplasma gondii non-specific serine/threonine protein kinase 0.0084 0.0047 0.1478
Schistosoma mansoni phosphatidylinositol 3-and 4-kinase 0.0134 0.0316 1
Entamoeba histolytica FKBP-rapamycin associated protein (FRAP), putative 0.0134 0.0316 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0134 0.0316 1
Echinococcus multilocularis DNA dependent protein kinase catalytic subunit 0.1921 1 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0134 0.0316 1
Loa Loa (eye worm) hypothetical protein 0.0084 0.0047 0.1478
Giardia lamblia GTOR 0.0134 0.0316 0.5
Trichomonas vaginalis PIKK family atypical protein kinase 0.0134 0.0316 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0134 0.0316 1
Trypanosoma brucei phosphatidylinositol 3-related kinase, putative 0.0134 0.0316 1
Loa Loa (eye worm) phosphatidylinositol 3 0.0134 0.0316 1
Entamoeba histolytica phosphatidylinositol3-kinaseTor2, putative 0.0134 0.0316 1
Brugia malayi Phosphatidylinositol 3- and 4-kinase family protein 0.0134 0.0316 1
Brugia malayi Phosphatidylinositol 3- and 4-kinase family protein 0.0134 0.0316 1
Echinococcus granulosus FKBP12 rapamycin complex associated protein 0.0134 0.0316 0.0316
Trichomonas vaginalis PIKK family atypical protein kinase 0.0084 0.0047 0.1478
Echinococcus multilocularis FKBP12 rapamycin complex associated protein 0.0134 0.0316 0.0316
Trichomonas vaginalis PIKK family atypical protein kinase 0.0134 0.0316 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0134 0.0316 1
Echinococcus granulosus phosphatidylinositol 3 and 4 kinase 0.0134 0.0316 0.0316
Trypanosoma brucei phosphatidylinositol 3-kinase, putative 0.0134 0.0316 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0134 0.0316 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0134 0.0316 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0134 0.0316 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0134 0.0316 1

Activities

Activity type Activity value Assay description Source Reference
EC50 (functional) = 0.01 uM Agonist activity at human cloned adrenergic beta2 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol ChEMBL. 19581100
EC50 (functional) = 0.09 uM Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol ChEMBL. 19581100
EC50 (functional) = 0.23 uM Agonist activity at human cloned adrenergic beta3 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay ChEMBL. 19581100
EC50 (functional) = 0.58 uM Agonist activity at human cloned adrenergic beta3 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol ChEMBL. 19581100
EC50 (functional) > 100 uM Agonist activity at human cloned adrenergic beta2 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay ChEMBL. 19581100
EC50 (functional) > 100 uM Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay ChEMBL. 19581100

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.